Add Row 
Add 
The Critical Need for Coverage of Breakthrough Medical Technologies
For patients facing serious health conditions, the availability of breakthrough medical technologies can be life-changing. However, the vast gulf between FDA approval and Medicare coverage continues to hinder patient access. As a physician and inventor, I understand first-hand that more treatment options improve outcomes. The FDA has implemented a breakthrough program to accelerate reviews of devices aimed at serious conditions, but millions of patients remain without the options they need due to Medicare’s complex coverage processes.
Why Congress Must Act Now
The passage of the 21st Century Cures Act in 2016 represented an essential step toward providing new treatment options. Unfortunately, even after FDA authorization, new technologies often take years to secure Medicare coverage. A study from the Stanford Mussallem Center reveals that, on average, it takes about 5.7 years for breakthrough technologies to receive even nominal coverage under Medicare. This time lag results in what industry experts refer to as the “valley of death,” prolonging needless suffering for Medicare beneficiaries.
Bipartisan Support Highlights Urgency
Recently, bipartisan support has surged for legislation aimed at expediting Medicare coverage for these vital innovations. The House Committee on Ways and Means voted overwhelmingly in favor with a 37-3 majority. Critics of this legislation argue, often erroneously, that quicker coverage will inflate healthcare costs. In reality, the number of devices eligible for expedited coverage is minimal when compared to the FDA's stringent approval process, ensuring patient safety and efficacy.
The Economic and Health Implications
According to the Congressional Budget Office, the cost of this initiative would be around $100 million annually, a fraction of the projected $1.5 trillion Medicare budget. When considering the potential for getting patients back to healthier, more productive lives, the benefits far outweigh these costs. If we fail to address this, we risk not just patient health but the U.S. leadership in medical technology innovation, as countries like China position themselves to take our place.
Optimism for Change in Healthcare Innovation
As discussions continue, Congress must prioritize closing the “valley of death” for breakthrough technologies. Effective policies could lead to widespread access to effective innovations needed to enhance patient care. Let’s hope lawmakers act swiftly to strike this balance between timely access to crucial medical technologies and safeguarding patients’ well-being.
Write A Comment